Our Services

Reformulating the Future of Medicine.

Formulated Delivery

Beyond molecular engineering, BCS2 develops novel, patient-centric delivery systems such as oral sprays, dissolvable films, nasal mists, and gummies. These formulations are designed to bypass the gastrointestinal tract and avoid first-pass metabolism in the liver, which leads to faster onset of action and more consistent bioavailability while addressing patient accessibility issues like dysphagia. The company provides end-to-end capabilities, offering fee-for-service reformulation programs for pharmaceutical partners and licensing its ever-expanding library of protected intellectual property for ongoing royalties.

API Solubility

BCS2 specializes in AI-driven pharmaceutical reformulation, focusing on improving the effectiveness and efficiency of proven active pharmaceutical ingredients (APIs). The company utilizes a proprietary AI algorithm to perform predictive screening and precision solvent matching, which identifies the optimal pathway to solubilize "intractable" drugs. This systematic approach replaces traditional trial-and-error R&D, significantly increasing the solubility of poorly soluble compounds—often by 10 to 100 times or more—to rescue high-value drug candidates and extend their product lifecycles.